MedTrace Logo

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

NCT04829903 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2022-03-14

No results posted yet for this study

Summary

To compare the efficacy and effect on glycemic control of Dulaglutide versus Liraglutide in obese Type 2 diabetic adolescents using metformin

Conditions

  • Type 2 Diabetes Treated With Insulin
  • Obesity
  • Adolescent Obesity

Interventions

DRUG

Dulaglutide

Dulaglutide injections

DRUG

Liraglutide

Liraglutide injections

Sponsors & Collaborators

  • Corporacion Parc Tauli

    lead OTHER

Principal Investigators

  • Nadia Hussain, PhD · Al Ain University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-02
Primary Completion
2021-03-29
Completion
2021-11-20

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04829903 on ClinicalTrials.gov